About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

STRONG Program for Cancer Patients

NCT05649969·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

H. Lee Moffitt Cancer Center and Research Institute

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Gastrointestinal Cancer diagnosis (e.g., colon cancer, appendiceal cancer)
Peritoneal disease diagnosis
Received Cytoreductive Surgery and Heated Intra-Peritoneal Chemotherapy (CRS-HIPEC) for curative intent at Moffitt
Transitioned to an oral diet post-surgery
Able to speak and read English
Able to provide informed consent

You may not be if

Documented or observable psychiatric or neurological disorder that would interfere with study participation (e.g., psychosis, active substance abuse)
Undergoing concurrent treatment for a secondary primary cancer
Receipt of parenteral or enteral nutrition after surgery

The record

StatusCompleted

PhaseNo phase

Taking part10

StartedDec 2022

UpdatedFeb 9, 2026

Conditions

Gastrointestinal Cancer

Where1

Moffitt Cancer Center
Tampa, Florida, United States

Clareo Health | STRONG Program for Cancer Patients